Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial - PubMed https://t.co/UzAXOBBl0g
720 followers
294 followers
RT @ShingoHatakeya1: メモ… アルツハイマー病(軽度~中等度)で治療を受けている患者を対象に、経口チロシンキナーゼ阻害薬(TKI)masitinibの上乗せ効果を検証するRCT。プラセボと比べmasitinib上乗せで認知機能が有意に改善。Alzheimer…
294 followers
RT @fneurociencias: Big news!! #Masitinib (4.5 mg/kg/day) has shown benefit in the treatment of people with mild-to-moderate # Alzheimer's.…
5,283 followers
Big news!! #Masitinib (4.5 mg/kg/day) has shown benefit in the treatment of people with mild-to-moderate # Alzheimer's. A confirmatory study has been initiated to further substantiate these data https://t.co/QwHFN7cSdQ